Insulin sensitivity and body composition in children with classical and nonclassical congenital adrenal hyperplasia

R M Williams1, A Deeb, K K Ong

  • 1Department of Paediatrics, University of Cambridge, Cambridge, UK.

Insights

Congenital adrenal hyperplasia (CAH) in children is linked to body composition changes. Classical CAH shows increased fat mass, while nonclassical CAH exhibits higher lean mass and insulin resistance indicators.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Genetics and Rare Diseases

Background:

  • Congenital adrenal hyperplasia (CAH) is associated with altered body composition and insulin sensitivity.
  • Understanding these metabolic differences in pediatric CAH is crucial for management.

Purpose of the Study:

  • To assess insulin sensitivity and body composition in children with classical and nonclassical CAH.
  • To compare these parameters with healthy controls to elucidate underlying mechanisms.

Main Methods:

  • Compared 37 children with CAH (classical and nonclassical) to 41 healthy controls.
  • Utilized DEXA for body composition and oral glucose tolerance tests for insulin sensitivity in pubertal children.
  • Statistical analysis adjusted for age, gender, and pubertal status.

Main Results:

  • Classical CAH children had significantly greater fat mass compared to controls.
  • Nonclassical CAH children showed increased lean mass and higher systolic blood pressure.
  • Pubertal nonclassical CAH children exhibited impaired glucose tolerance and insulin response.

Conclusions:

  • Increased fat mass in classical CAH may be due to long-term glucocorticoid therapy.
  • Greater lean mass and insulin resistance in nonclassical CAH suggest adverse effects of postnatal androgen excess.
Abstract

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.